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Worldwide, infectious diseases account for more than a 
quarter of human deaths annually1. The emergence and 
re-emergence of infectious pathogens and the continuing 
struggle to manage other diseases emphasize the chal-
lenges facing public health professionals. The optimism 
that marked an era when scientists were confident in 
the success of eradication efforts and declared victory in the 
fight against infectious agents has long since passed. 
The complex interactions among processes acting at 
different organizational levels that underlie the dynam-
ics of infectious diseases are now becoming evident. 
Mathematical models are central in providing insight 
into such complex interactions and in understanding why 
interventions that have a benefit for an individual may not 
ultimately be optimal for the population (for example, the 
use of antimicrobials). Mathematical models based on eco-
logical and evolutionary theory have been used to study 
pathogen invasion, persistence and evolution in human 
populations2. The predictions generated by these mod-
els have been pivotal tools in the process of public health 
decision making, forecasting the long-term epidemiologi-
cal and economical consequences of intervention strate-
gies. For example, mathematical models that examined 
strategies to mitigate the impact of an influenza pandemic 
have shaped the guidelines for preparedness and response 
to such an event3. In the absence of long-term follow-up 
clinical studies, mathematical models have also helped to 
evaluate the efficacy and delivery strategies of vaccines 
against human infections by pathogens such as human 
papilloma virus4, HIV5 and mycobacteria6. BOX 1 outlines 
the steps in the development of a mathematical model.
Mathematical modellers provide hypotheses with 
a rigorous test, but the models that they use often rely 
on untested assumptions. Empirical data are crucial for 
assessing whether these assumptions hold true and for 
determining the conditions under which model pre-
dictions are valid. For example, a common assumption 
of infectious disease models is that the infectious period 
is exponentially distributed, and theoretical studies 
have shown that changing this assumption has a pro-
found impact on the predicted infection dynamics7,8. 
Furthermore, assuming that the infectious period is 
exponentially distributed is not realistic for some dis-
eases9. Nevertheless, data on how infectious periods 
vary with factors such as pathogen strain, route of excre-
tion or initial infective dose are very limited, thus the 
exponentially distributed infectious period remains a 
routine assumption of models. Similarly, the transmission– 
virulence trade-off hypothesis has been the basis for most of 
the theory that has been developed through mathemati-
cal modelling of evolutionary epidemiology for the past 
three decades10, but this hypothesis has been increasingly 
challenged owing to the lack of empirical evidence11. 
Both examples underscore the importance of combining 
mathematical models and empirical data. The fields of 
experimental and mathematical epidemiology have been 
linked from their beginnings. In 1936, Greenwood et al.12 
published the first quantitative transmission experi-
ments, which were analysed the same year by Kermack 
and McKendrick in their highly influential series on the 
mathematical theory of epidemics13,14.
Empirical data can be obtained from field or experi-
mental settings using biological models of animal dis-
eases. Although these animal models have been widely 
used to explore pathology and pathogen dynamics at the 
cell and individual animal levels, their use to describe 
population-scale disease dynamics and their feedback 
interactions has been limited. Appropriately designed 
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Infectious period
The time period during which 
an infectious individual is able 
to transmit the pathogen to a 
susceptible host. The duration 
of the infectious period is 
exponentially distributed in 
deterministic models, in which 
the rate of infected individuals 
leaving the infectious class is 
constant, and in stochastic 
models, in which each 
infectious individual has a fixed 
duration of infectiousness 
drawn from an exponential 
distribution at random.
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Abstract | In recent decades, theory addressing the processes that underlie the dynamics of 
infectious diseases has progressed considerably. Unfortunately, the availability of empirical 
data to evaluate these theories has not grown at the same pace. Although laboratory animals 
have been widely used as models at the organism level, they have been less appropriate for 
addressing issues at the population level. However, farm animal populations can provide 
empirical models to study infectious diseases at the population level.
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studies involving animal models should also be used to 
improve our understanding of the impact of treatments 
and control strategies and the evolutionary dynamics 
of pathogens that take place at the population level. In 
addition, attempting to predict or control the evolution 
of drug resistance and virulence or to inform vaccine 
design requires animal models in which the interactions 
between processes acting at different organizational levels 
(for example, within a host and between hosts) can be 
quantified15.
The search for appropriate biological models to study 
infectious disease dynamics has often overlooked prom-
ising systems that are available in animal agriculture. 
Mathematical models in farm animal populations have 
been largely limited to offering guidance to veterinary 
decision making for pressing food protection, animal 
welfare and economic issues, such as those presented 
in outbreaks of bovine spongiform encephalopathy16 or 
foot-and-mouth disease17. We propose that farm animal 
populations, coupled with mathematical models, are 
well-suited model systems to study infectious-disease 
population dynamics and problems that span several 
levels of organization and that are relevant to the control 
of human infectious diseases. We discuss the features, 
advantages and disadvantages of these systems and high-
light research areas that might benefit from the knowl-
edge generated by studying infectious disease dynamics 
in farm animal populations.
Farm animals as natural infection model systems 
In this section, we discuss the key features of the farm 
animal systems that are relevant to infectious disease 
dynamics, with emphasis on the similarities and differ-
ences between farm animals and humans at the popula-
tion level (BOX 2). Pathogen–host systems in which the 
pathogen is studied in its natural host are necessary to 
investigate infectious disease dynamics at the population 
level. In surrogate models, the pathogen does not natu-
rally infect the host animal outside a laboratory setting, 
and high doses of the pathogen administered through 
artificial transmission routes are often necessary to induce 
infection18. These issues complicate the study of pathogen 
transmission in the surrogate model, because it may not 
take place at all or it may result in invalid measures of 
pathogen life history traits such as the duration of the 
infectious period. laboratory animals, especially mice, 
have been the main animal models for studying specific 
aspects of human pathogenesis and immunity. However, 
mice are more often surrogate models than natural 
models for the pathogen under study. At the individual 
level, farm animals are being used as natural models for 
a wide range of human infectious diseases (TABLE 1). In 
many cases, humans and farm animals share pathogens. 
More than half of human infectious diseases are caused 
by multihost pathogens19, for which farm animals are 
often natural hosts and serve as an important infection 
reservoir for humans20. Farm animals are therefore good 
candidates for studying infectious disease dynamics at 
the population level.
There are many similarities in the underlying prin-
ciples that govern infection transmission in human and 
farm animal populations, which allows us to use the ani-
mal system as a model. At the population level, livestock 
production systems include a range of population settings 
and contact structures, including backyard poultry flocks, 
highly extensive herds and highly controlled production 
Box 1 | Developing a mathematical model
Mathematical modelling facilitates inference from biological model systems. There are 
four steps in the modelling of an infectious disease, illustrated by th  following outline  
of the steps used for the modelling of a multidrug-resistant Salmonella enterica subsp. 
enterica serovar Newport (S. Newport) outbreak in a calf-raising facility (see the figure; 
part a shows the prevalence and location of the affected animals in the outbreak, with 
green indicating clinical cases and red indicating deaths, and part b shows a flow 
diagram representation of the model)23.
Formulate the research question
The most important step in modelling is the formulation of the research questions. These 
questions provide criteria to help researchers decide which elements of the system under 
study must be included in the model. In the case of the S. Newport outbreak, these 
include questions such as: what factors contribute to the transmission and persistence  
of the outbreak, and what are the best control strategies to stop outbreaks?
Develop the mathematical model
To develop a mathematical model, the variables and assumptions to be included in the 
model need to be defined. Then a flow diagram is drawn to describe the changes to 
these variables over time. The modeller must then decide whether a deterministic or 
stochastic model is appropriate and write the mathematical equations. The animals in 
the calf-raising facility are individually penned animals (see the figure, part a), and 
therefore transmission of the pathogen is through contaminated fomites and mechanical 
vectors. In this situation, an indirect SIR transmission model (which classifies individuals 
as susceptible, infectious or recovered) is appropriate, in which the host population is 
divided according to their epidemiological status.
Analyse the mathematical model
Based on simulations, a model analysis is chosen that best addresses the problem. 
Threshold values and conditions for invasion and persistence of the pathogen are 
evaluated and scenarios simulating control strategies are run.
Validate the mathematical model
The results of the simulations are checked against data or known cases. Alternatives to 
the model and to the assumptions are considered.
relate the model back to the research question
The results from the previous step are interpreted to assess whether the results 
answer the research question. During the outbreak of S. Newport, environmental 
reservoirs, the high turnover rate of individuals and the continual admission of 
susceptible individuals favour persistence. Immunization of a high proportion  
of admitted individuals (>75%) and completely closing off facilities to reduce  
the effective contact rate by allocating personnel and equipment to subgroups  
were effective strategies to control outbreaks.
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Transmission–virulence 
trade-off hypothesis
The proposal that increased 
host survival and, therefore, 
pathogen transmission 
represent a trade-off for the 
parasite: high parasite 
reproduction in the host and 
high levels of virulence can 
cause host death, reducing the 
chances of the parasite being 
transmitted to another host.
Stochastic model
A mathematical model that 
incorporates elements of 
chance. Stochastic models are 
necessary when small 
populations, such as those in a 
transmission experiment, are 
being modelled.
Organizational level
Living entities are organized in 
hierarchical levels (for example, 
cell, individual, population and 
ecosystem). Each level of 
organization builds on the level 
below it but often has 
emergent properties (that is, 
properties that result from the 
interactions between the parts 
of the level below).
management systems. Factors that contribute to animal 
disease outbreaks (for example, crowding, close contact, 
poor hygiene and contaminated fomites) are common to 
human settings such as hospitals, army camps, schools, 
daycare facilities and dense urban areas21,22. From a pop-
ulation dynamics point of view, both calf-rearing units 
and health care settings are small, transient populations; 
a high turnover rate of individuals in the facility, the 
presence of environmental reservoirs of infection and 
continuous antimicrobial selective pressure prolong the 
transmission of multidrug-resistant clonal pathogens in 
both situations23,24. Furthermore, heterogeneities that 
lead to differences in infectiousness and transmission 
dynamics are often similar across different combinations 
of hosts and pathogens25. Factors that influence the infec-
tion process and transmission dynamics in both animals 
and humans include age, nutritional health, vaccination 
history, physiological state and genetic heterogeneity of 
the host, as well as environmental factors such as hygiene 
and the type of social interactions and contacts that occur 
in the population. It should be noted, however, that at 
certain spatial scales transmission dynamics between 
farm animals and human populations may not be com-
parable. For example, transmission at large spatial scales 
can be dissimilar, as networks of livestock and human 
movements can differ substantially26. In addition, the 
progress made in our understanding of those farm ani-
mal diseases that have wildlife reservoirs (for example, 
bovine tuberculosis) has been slowed owing to the dif-
ficulties in characterizing transmission between domestic 
and wild animals.
In agricultural systems, decisions regarding the 
use of intervention strategies are based on individual 
and population health (of both the animals and their 
human carers), animal welfare, food safety and eco-
nomic considerations. Because of the need to balance 
these considerations, infectious disease management 
makes use of diverse control options; for example, vac-
cines that do not prevent transmission but do reduce 
clinical disease are used to reduce the economic burden 
of diseases27. Vaccines with diverse modes of action (for 
example, inhibition of pathogen growth rate or toxicity, or 
blocking transmission) and a range of vaccination strat-
egies (for example, cohort or continuous vaccination) 
are used for farm animals. other control strategies used 
for animal diseases include surveillance, environmental 
hygiene, ‘all-in, all-out’ management (in which animals 
are managed in groups, and cleaning and sanitation of 
facilities is carried out before introducing a new group) 
and targeting of specific groups (for example, the detec-
tion and treatment (‘test and treat’) or culling (‘test and 
cull’) of infected animals)28. The wide range of available 
control strategies for farm animal diseases has contrib-
uted to the unravelling of infectious disease dynamics. For 
instance, endemic stability is an epidemiological concept 
that is well described in veterinary medicine, especially in 
tick-borne diseases, and that may also be relevant to the 
control of a wider range of diseases, including malaria or 
dengue in humans. At endemic stability, the clinical dis-
ease prevalence is low despite high levels of infection in 
the population, because immunity is acquired at a young 
age, when the disease is milder29. Decreasing transmis-
sion increases the age at which animals become infected, 
thus increasing the percentage of infections that result in 
clinical disease. Not controlling infection transmission is 
considered a more sustainable option than partial con-
trol in this case, because higher transmission rates result 
in lower clinical disease levels. It was hypothesized that 
endemic stability could be observed in all human and 
animal diseases for which the probability or severity of 
clinical disease increases with age and the probability 
of disease is reduced after two or more infections29. This is 
illustrated by the results of the control measures that were 
taken for dengue. Dengue is a mosquito-borne viral dis-
ease that can cause symptoms ranging from mild fever to 
life-threatening haemorrhagic fever. For decades, several 
Asian countries, including Thailand and Singapore, have 
applied vector control programmes to control dengue. 
Despite these measures, the incidence of dengue cases has 
not declined. The stagnant incidence was initially attrib-
uted to the failure of the vector control programmes to 
decrease transmission, but analysis of the epidemiological 
data revealed that virus transmission has decreased, and 
the increase in dengue cases at lower transmission rates 
may result from the loss of endemic stability30,31.
Infectious disease dynamics in farm animals
To study the complex processes underlying infectious 
disease dynamics, approaches that integrate different 
fields and methods are required. By gathering scientific 
evidence about the host–pathogen systems through 
experimental, field, model and historical investigations 
at different organizational levels, a complete picture of 
the causal mechanisms shaping the infection dynamics 
can be uncovered32. using challenge and transmission 
experiments carried out in animal agriculture systems, 
Box 2 | Features of farm animal populations that are relevant to their potential use as models
• The disease mechanisms and immune systems are sufficiently similar between some farm animals and humans.
• The populations are outbred.
• Natural transmission takes place, and quantification of life history traits, including infectious period and transmission rate, 
is feasible.
• The populations are highly stratified with multiple sources of heterogeneity (for example, spatial, genetic and 
management factors and age) that can be readily manipulated.
• We have extensive knowledge of the host–pathogen systems.
• Diverse interventions are logistically and ethically feasible.
• Long-term interventions such as mass vaccination programmes are applied.
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large-scale and long-term field data can be gathered on 
the same host–pathogen system, and thus model systems 
that span several organizational levels can be obtained.
understanding infectious disease dynamics often 
requires gathering data to estimate virulence, infectious-
ness and transmission, and such data can be obtained from 
farm animal populations. Pathogen excretion has been 
more readily quantified in farm animals than in humans. 
Listeria monocytogenes infection in cattle has been used as 
a biological model to develop a mathematical approach to 
quantify the duration and frequency of shedding episodes 
for pathogens that have an oral–faecal mode of transmis-
sion33; this is a route of transmission for many important 
human infectious agents, including Salmonella and hepa-
titis A virus. Transmission information can be obtained 
from experiments or field studies, which are often used 
to test interventions such as vaccination. Experimental 
studies testing vaccines have characterized their effects at 
both the individual and population levels34 using group 
or one-to-one transmission experiments (FIG. 1). Statistical 
methods based on stochastic transmission models have 
been developed to quantify transmission parameters and 
pathogen life history traits35. In controlled conditions, the 
contribution of specific aspects affecting transmission can 
also be studied35. The effect of expressing an F4 recep-
tor for intestinal adhesion of the F4 fimbrial antigen of 
Escherichia coli on the susceptibility and infectivity of pig-
lets to E. coli infections was quantified by testing all pos-
sible combinations in one-to-one experiments, in which 
one infectious animal (either positive or negative for the 
F4 receptor) was housed with one susceptible animal 
(either positive or negative for the F4 receptor)36. F4 recep-
tor-positive piglets were more susceptible, and the maxi-
mum proportion of F4 receptor-positive piglets that can 
be present in a population without outbreaks occurring 
was estimated to be 0.14.
Quantitative experiments in veterinary medicine using 
farm animals have linked transmission measurements 
to within-animal dynamics (for example, the pathogen 
load and the immune response)37–39, and thus detailed 
information such as time-dependent infectiousness can 
be quantified40. Combined quantitative information 
about within-host dynamics and transmission is crucial 
to parameterize and validate mathematical models that 
seek to understand pathogen evolution.
using field and historical data, the long-term effects of 
control strategies can be investigated. In field studies, ani-
mal productivity and health databases are often available 
and can provide extensive information on health, man-
agement and disease control. It is not unusual for a typical 
farm to know at any given time exactly how many animals 
are present, the density at which they have been held, what 
they are eating and drinking, their deep geographic and 
genetic pedigrees, their clinical disease states and histo-
ries, their ages and how these age-structured classes have 
been stratified, and measures of their performance and 
production in detail. In human and wild-animal systems, 
information regarding movements, density, contacts and 
even population size are often unknown, even to an order 
of magnitude. In farm animals, information at lower hier-
archical levels (such as at the organ or tissue level) can 
be gathered by biological and post-mortem sampling. 
Biological sampling can be performed on a regular basis 
and can be accomplished easily, with minimal disturbance 
to the animals; necropsies are commonly performed on 
either culled or dead animals, and carcasses are inspected 
at the abattoir. owing to legal requirements, data describ-
ing the network of animal movements between farms are 
available in some countries. Combined, these data provide 
far richer information about infectious diseases dynam-
ics across scales than is typically available in wildlife or 
human systems.
Table 1 | Farm animal models for human pathogens or diseases
Animal pathogen Farm animal 
hosts
Human disease or 
pathogen





Cattle Human papilloma 
viruses
Latency mechanisms of papilloma 








encephalitis virus and 
Visna/maedi virus









Therapeutic treatment testing and 
clinical responses to diverse strains
101
Hepatitis E virus Swine and chickens Hepatitis E Mechanisms of pathogenesis and 
vaccine development
102
Marek’s disease virus Chickens Virus-induced 
lymphoma
The role of immune control and 
evasion in neoplasma formation 
and mechanisms of virus-induced 
lymphoma
48
Mycobacterium bovis Cattle, goats and 
swine
Human tuberculosis Mechanisms of pathogenesis, host 
defences and vaccine development
103,104
Salmonella enterica Cattle (calves) Human enteritis The role of virulence factors 
on infection and S. enterica 
pathogenesis
105
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Host–pathogen model systems in farm animals
An outline of some areas of fruitful work using animal 
agricultural models is presented in TABLE 2, with empha-
sis on those models that are relevant to human health, 
and we briefly discuss some examples of these research 
areas below.
Vaccine research. Vaccination has been a very success-
ful control strategy for several diseases, including yel-
low fever, hepatitis A and childhood diseases, providing 
life-long immunity. However, vaccines are now being 
developed for human and animal pathogens that have 
fast antigen variability (for example, the influenza virus) 
or short natural immunity (for example, malaria para-
sites) or that induce a cell-mediated immune response 
(for example, HIV and Mycobacterium tuberculosis). For 
these pathogens, the available vaccines are imperfect, as 
they do not stop individuals from becoming infected on 
exposure to the pathogen. Imperfect vaccines can alter 
the selective pressures imposed on pathogens and, thus, 
potentially alter the evolution and composition of patho-
gen communities41. Mathematical models investigating 
the evolutionary consequences of the use of imperfect 
vaccines have been developed in recent years42–44. These 
models have investigated the short-term and long-term 
evolution of a pathogen under vaccine pressure and have 
suggested that vaccines reducing the fitness cost of viru-
lence (for instance, by reducing host death) may favour the 
spread of more virulent strains in the vaccinated popula-
tion. It was concluded that vaccines that are designed to 
reduce pathogen growth rate or toxicity could lead 
to increased pathogen virulence42, which could cause 
more severe disease in unvaccinated individuals. To 
predict the direction and speed of evolution, measures 
of the life history traits (including the transmission rate, 
the infectious period and virulence) in both vaccinated and 
naive hosts are necessary44. Tracking virulence changes in 
humans is difficult, as exposing humans to virulent strains 
is unethical, and historical data is confounded by changes 
in factors such as medical treatments45.
Except for laboratory experiments with rodent 
malaria46, the only reported cases of increased virulence 
for a pathogen under vaccine selective pressure have 
been in domestic animals. In commercial chickens, two 
generations of vaccines against Marek’s disease virus have 
been abandoned (reviewed in REF. 47). Marek’s disease, 
caused by an alphaherpesvirus, is a lymphoproliferative 
disease that has caused major economic losses to the 
poultry industry owing to its high morbidity and mortal-
ity47. The first vaccine against Marek’s disease virus was 
introduced in 1969, but in the late 1970s a more virulent 
pathotype emerged and prompted the deployment of a 
new vaccine. In the early 1990s another virulence shift 
took place, followed by the development of a new vac-
cine47. The evolved mutants have the same epitopes as 
strains from the pre-vaccine era but have shown greater 
viral replication and higher immunosuppressive capa-
bilities47. Marek’s disease is a unique empirical model 
to study virulence evolution in vaccinated populations. 
Marek’s disease in chickens is already used as an animal 
model to study vaccine immunity to cancer and viral-
induced oncogenic transformations48. New knowledge 
in evolutionary epidemiology may lead to the inclusion 
of evolutionary considerations in vaccine design and 
development.
Antimicrobial resistance. The increase in the prevalence 
of infections that are caused by antimicrobial-resistant 
organisms is linked to the intensity of the selection that 
is imposed by the use of antimicrobials, and therefore 
infections with antimicrobial-resistant bacteria are espe-
cially common in health care facilities and on farms, 
where antimicrobial use is intensive. Transmission of 
clones of resistant bacteria between individuals is key 
for the dissemination and persistence of antimicrobial-
resistant pathogens, both in health care facilities49,50 
and on farms51. The decrease in antimicrobial pressure 
has not always resulted in a decrease in antimicrobial-
resistant bacteria at the population scale, however52. 
The mechanisms and determinants responsible for the 
persistence of antimicrobial resistance remain largely 
unknown, although several mechanisms have been pos-
tulated, including compensatory mutations that reduce 
or revert fitness costs53, co-selection with heavy metals 
and biocide resistant genes54, and increased horizontal 
gene transfer under stress responses55. The determinants 
leading to the persistence of antimicrobial resistance can 
be studied systematically in farm settings, because the 
suspected determinants can be manipulated at the popu-
lation level. For example, the determinants responsible 
for the persistence of commensal E. coli that is resistant 
to streptomycin, sulphonamide and tetracycline in dairy 
calves were investigated in a series of studies56–59. Three 
Figure 1 | Designs of transmission experiments. a | One-to-one experiments. One 
infectious animal (I) is housed with one susceptible animal (S)96. A transmission chain can 
be obtained by using the infected animals to infect the next generation of susceptible 
animals. b | Group experiments. A number of infectious and susceptible animals are 
housed together97. c | Extended transmission experiments. Artificially inoculated animals 
are mixed with susceptible animals. Artificially inoculated animals are removed, and the 
newly infectious animals (yellow and green), infected by contact with the inoculated 
animals, are used to start the transmission experiment by mixing them with new 
susceptible animals (blue)39. This design is useful when the artificial inoculation creates 
highly infectious animals; however, the initial infection process is less controlled. Aspects 
that need to be considered in the design of the experiment are the infection route, 
inoculation dose, mathematical model and statistics used to infer transmission parameters.
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hypotheses were tested: that the direct antimicrobial 
selection pressure maintains the high prevalence of the 
resistant strain; that the resistant strain provides a sec-
ondary advantage; and that a milk supplement (skimmed 
milk with vitamins D and A) provides a selective advan-
tage. The persistence of the resistant E. coli in calves was 
found to be linked to the consumption of the vitamin D 
that was present in the milk supplements56–58. These 
studies showed that there can be a causal link between 
factors other than antimicrobial presence and the 
persistence of the antimicrobial resistance.
Field studies have been used to monitor the persist-
ence of antimicrobials after the reduction of their use 
in farms. Antimicrobial pressure on farms ranges from 
non-existent (in antimicrobial-free farming systems) 
to high levels, as antimicrobials are used at different 
doses depending on the purpose (for example, thera-
peutic versus growth promoter uses). Studies compar-
ing conventional and organic farms have shown that 
the level of antimicrobial resistance of enteric bacteria 
was lower on organic farms than on conventional farms, 
but that the difference in levels varied depending on the 
Table 2 | The use of farm animal populations to study infectious-disease dynamics
research area Animal pathogen or disease Animal model or system refs
Vaccine research
Evolution of pathogen virulence and 
antigenic escape
Marek’s disease Poultry 47
Infectious bursal disease Poultry 106
Avian influenza Poultry 107
Foot-and-mouth virus Ruminants 108
Vaccine design for multistrain or 
multihost pathogen systems




Emergence and persistence of 
resistance
Multidrug-resistant Salmonella spp. strains Dairy cows 110
Methicillin-resistant Staphylococcus aureus Swine N/A
Escherichia coli Swine and dairy cows 63
Transmission dynamics
Feedback between the within-host 
pathogen dynamics and transmission
Foot-and-mouth virus Ruminants and swine 69
Empirical testing of transmission rate 
formulations and contact patterns
Multiple pathogens Closed herds 35
Effect of infection imports on 
occurrence, frequency and 
persistence of disease outbreaks
Multiple pathogens Connected open herds 111
Host heterogeneity
Genetic determinants of vaccine 
responses
Foot-and-mouth virus Ruminants 112
Marek’s disease Poultry 47
Genetic determinants of disease 
susceptibility
Marek’s disease Poultry 48
Nematode parasites Sheep 75
Trypanosoma congolense and  
Trypanosoma vivax
Cattle 113
E. coli Swine 36
Dynamics of polymicrobial diseases
Dynamics of multiple colonizations 
and transmission dynamics
Bovine respiratory disease complex Cattle 114
Porcine gastroenteritis Swine 115
Emergence of new strains and cross-species infections
Mechanisms of emergence of 
new strains and cross-species 
transmission
Avian influenza Live-bird markets 94
Hepatitis E Swine 102
Influenza Swine 82
Dynamics of chronic infections
Dynamics of host–pathogen 
interactions and the determinants of 
persistence at the population level
Johne’s disease Dairy cows 28
Mastitis Dairy cows 116
N/A, not applicable.
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Genetic hitchhiking
A process in which alleles 
increase their frequency in the 
gene pool because they are 
associated with alleles at 
genetically linked loci that  
are favoured by selection.
Overdispersed
Pertaining to a distribution with 
a variance that is greater than 
the mean. For parasites, this 
occurs when many hosts 
harbour a few parasites and  
a few hosts harbour a large 
number of parasites.
Basic reproduction number
The expected number of 
secondary cases infected by 
transmission from a typical 
infected individual during that 
individual’s entire period of 
infectiousness in a completely 
susceptible population.
Reassortment
The exchange of genetic 
material between genetically 
different viruses that are 
infecting the same cell. It can 
result in the generation of a 
novel strain. 
antimicrobial60–62. The influence of antimicrobial selec-
tion on the genetic composition of E. coli populations 
was studied by comparing E. coli isolates from both 
organic and conventional farms63. organic farm iso-
lates had lower ampicillin resistance than conventional 
farm isolates, which showed clonal resistance, but tetra-
cycline resistance persisted in organic farms, probably 
owing to genetic hitchhiking. Such studies can aid in pre-
dicting when antimicrobial reduction policies might be 
successful in human populations, as well as helping to 
determine the time that is necessary for antibiotic resist-
ances to revert. In this regard, longitudinal studies of 
herds undergoing the transition to organic farming, in 
which antimicrobial resistance and the genotypes of the 
pathogens found in the farm are characterized, would 
be especially helpful.
Transmission dynamics. Transmission is the key pro-
cess underlying infectious disease dynamics. Infectious 
disease models use varying transmission formulations 
that convey different assumptions about the structure of 
contacts among individuals of the population and their 
scaling with population density64. The predictions of the 
models can vary greatly when different transmission 
formulations are used, but empirical studies comparing 
these formulations are limited65. In human populations, 
the scaling of transmission rates with host population 
size and type of mixing (that is, homogeneous or hetero-
geneous) has only been assessed for measles, for which 
there are good data records for both large and small 
communities66. Experimental transmission studies in 
farm animals have evaluated the effect of density and the 
scaling of contact-based transmission67,68. understanding 
how pathogen transmission in a population is affected 
by the pathogen dynamics within the host is impor-
tant for predicting outbreaks and pathogen evolution15. 
Quantitative data linking both scales are limited, but 
some studies in veterinary medicine suggest that small 
differences in the observed duration of latent and infec-
tious periods for the individual host can result in large 
differences in pathogen transmission at the population 
level37. latent and infectious periods were estimated for 
equine influenza viruses in animals vaccinated with a 
homologous (immunologically identical) strain or 
a heterogenous (immunologically similar but not iden-
tical) strain. Vaccine escape, occurring in animals vac-
cinated with the heterogeneous strain, increased the 
duration of the infectious period. Studies that quantify 
transmission and within-host dynamics have also been 
conducted for foot-and-mouth disease in different spe-
cies69, which provided unique data on a pathogen’s life his-
tory traits, including the relationship between pathogen 
load and transmission.
Host heterogeneity. Pareto’s law is pervasive in trans-
mission dynamics; it states that 20% of infected indi-
viduals contribute 80% of the net transmission for a 
wide range of diseases25. Transmission is influenced 
by many sources of heterogeneity, including behav-
ioural and genetic factors, age, vaccination status and 
nutrition70,71. untangling the causes and providing an 
accurate representation of the population heterogene-
ity in models are important ongoing challenges in the 
study of infectious disease transmission dynamics and 
control71. A notable implication of the presence of hetero-
geneity on infection transmission is that individual-
specific control measures designed to target the most 
infectious individuals (such as isolation) or susceptible 
individuals (such as vaccination of high-risk individu-
als) are more efficient at controlling the transmission 
than population-wide control measures (such as vac-
cination at random)25,71. The distribution of helminth 
parasites between hosts is usually highly overdispersed72; 
in humans the relative roles of exposure and genetic 
resistance in generating the overdispersed distribution 
is unknown73. Arguably, gastrointestinal nematodes in 
livestock are one of the best understood of all host–
parasite systems, and extensive research to determine 
the sources underlying helminth overdispersion has 
been conducted74,75. A detailed quantitative genetic 
analysis indicated that additive genetic variation was 
the most important source of variability in faecal egg 
counts in sheep76. Two loci accounted for a large portion 
of the additive variation: the interferon-γ gene (IFNG) 
and the major histocompatibility complex class II 
Dr β-chain locus (DRB1)75. Genetic approaches are 
now being integrated with epidemiological models in 
order to quantify the contributions of the non-genetic 
and genetic variations in host immune responses to the 
observed transmission patterns and the impact of these 
variations on parasite control77.
Emergence of new pathogens. The interest in the emer-
gence of new infectious diseases has grown considerably 
owing to highly publicized cases such as highly patho-
genic avian influenza, swine-origin H1N1 influenza A 
and severe acute respiratory syndrome (SArS). The 
emergence of infectious diseases can be seen as a four-
step process78: exposure of a new host to the pathogen, 
infection of the new host, transmission within the new 
host population, and epidemic spread. Although there is 
agreement that both ecological and evolutionary factors 
contribute to this process, their specific contributions to 
driving the basic reproduction number above 1 and to the 
resulting epidemic spread in the new host is unknown. 
In addition, it is unclear at which step the evolutionary 
changes that favour crossing species barriers or transmis-
sion in the new host take place79. Monitoring the trans-
mission dynamics and the emergence of new pathogens 
among animals in agricultural systems provides an oppor-
tunity to study the mechanisms underlying emergence 
and to identify areas and pathogens from which the next 
human emerging infectious disease is likely to originate. 
Influenza viruses in farm animal populations not only 
serve as multiscale models for human disease, but also are 
major components of the natural system driving disease 
evolution and emergence into the human population.
The emergence of new influenza viruses is caused 
by reassortment involving human, swine or avian influ-
enza viruses or by host-switching events in which the 
accumulated mutations favour the emergence of new 
strains that are capable of crossing species barriers 
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Mixed vessel theory
New strains of influenza virus 
can emerge if an avian-origin 
virus and a human-origin virus 
simultaneously infect the same 
animal (for example, pigs). This 
dual infection can produce 
reassortants with pandemic 
potential, if the reassortant  
has the ability to transmit 
effectively through humans and 
if humans are immunologically 
naive to the new strain.
and adapting in a new host owing to the low fidelity 
of the viral rNA polymerase. Examples of reassorted 
viruses in humans include the H2N2 influenza virus 
that caused the 1957 outbreak of ‘Asian influenza’ 
and the H3N2 strain that caused ‘Hong Kong influ-
enza’ in 1968. The deadly H1N1 influenza pandemic 
in 1918 was probably due to a host-switching event 
and the consequent adaptation of an avian virus to 
humans80. During this pandemic, the H1N1 strain was 
also introduced into the pig population and evolved 
into the classic H1N1 strain that remained the pre-
dominant lineage in pigs in North America until the 
late 1990s81. In 1997–1998, two distinct H3N2 strain 
genotypes were identified in the North American 
swine population: a double human virus–swine virus 
reassortment and a triple avian virus–human virus–
swine virus reassortment82. The triple-reassortant 
H3N2 strain spread efficiently in the swine popula-
tion and has continued to evolve by genetic drift and 
by reassortment with the classic H1N1 strain83. This 
H3N2 strain is one of the progenitors of the newly 
recognized 2009 swine-origin H1N1 influenza virus84. 
other H1N1, H3N2 and H1N2 influenza virus strains 
circulate worldwide in swine populations, although 
their origins and nature varies depending on their 
geographical location81,85. In addition, transmission 
from swine to humans has been well documented 
and ranges from sporadic cases with no further 
human-to-human transmission86, to limited human-
to-human transmission (for example, the Fort Dix 
influenza outbreak in 1976)87, to extensive human-
to-human transmission (for example, the 2009 
swine-origin H1N1 influenza virus)88.
This extensive accumulated knowledge about the 
dynamics of influenza viruses in swine populations 
and their potential to emerge into human pathogens 
makes them a suitable model to study the ecology of 
influenza viruses. Comparisons among the influenza 
viruses found in swine populations have provided 
insights into the molecular basis of influenza trans-
missibility and the role of swine in the mixed vessel 
theory82. Empirical evidence for the three components 
of the mixed vessel theory, including the findings that 
swine are susceptible to avian and human influenza A 
viruses, that reassortment between swine, avian and 
human viruses takes place in the pig and that pigs 
can transmit reassortant viruses to humans, have 
been documented82. Host-switching events have also 
been observed in swine populations. For example, 
in 1979 an avian H1N1 strain crossed the species 
barrier and established a new lineage in swine. This 
lineage provided a model for studying the early evo-
lution of influenza viruses89,90. Comparisons with the 
classic swine H1N1 strain, circulating since 1918, 
indicated that influenza viruses have weak host-
specific adaptation, as no common genetic changes 
related to the host-switching event were identified. 
This suggests that we have a limited ability to predict 
potential emergent avian influenza viruses by identi-
fying specific polygenic changes that are indicative of 
mammalian adaptation89. More recently, other host-
switching events without reassortment have been 
described, including other avian-to-swine switches, 
such as the H2N3 strain in the united States91, as well as 
equine-to-dog switches92.
Surveillance in live-poultry markets serves as an 
early warning system of emerging influenza viruses 
and has provided another battleground for studying 
the ecology of this virus93. live-poultry markets bring 
together a number of hosts (including humans) of 
multiple origins in a high-density setting. Studies on 
the gene pool of the influenza viruses circulating in 
live-poultry markets have found evidence for differ-
ent propensities of reassortment among subtypes and 
have identified quails as another species that acts as a 
mixing vessel for avian and human influenza viruses94. 
The complex interaction between influenza ecology 
and evolution across hierarchical scales cannot be 
completely replicated in artificial laboratory settings. 
The study of influenza emergence requires the use of 
natural mixing patterns, including those observed in 
swine and poultry management systems.
Conclusions
Infectious diseases in farm animals are often studied 
because they represent an economic cost or a zoonotic 
risk. Here we present yet a third important reason for 
such work: infectious diseases in farm animals can be 
used as biological models to provide empirical data that 
aids infectious disease modelling and to advance our 
understanding of infectious disease dynamics and con-
trol for human populations. As rudolf Virchow, father of 
the field of pathology, said: “Between animal and human 
medicine there is no dividing line — nor should there 
be. The object is different but the experience obtained 
constitutes the basis of all medicine.” (REF. 95.)
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